NEW YORK (GenomeWeb News) – HairDx today said that it has signed up a distributor in the Dominican Republic for its genetic baldness tests.

The firm said that the Skin and Hair Transplant Institute of Santo Domingo will introduce the tests in the country. Terms of the agreement were not disclosed.

"The genetic tests made by HairDX … give important information about responsiveness to patients considering Finasteride treatment," Alba Reyes Sagiv, who runs the institute, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.